학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 78건 | 목록 1~10
Academic Journal
Taskén K; Institute for Cancer Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway. kjetil.tasken@medisin.uio.no.; F Haj Mohammad S; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands. s.f.haj_mohammad@lumc.nl.; Fagereng GL; Institute for Cancer Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway. gfageren@ous-hf.no.; Sørum Falk R; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway. rs@ous-hf.no.; Helland Å; Institute for Cancer Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway. aslaug.helland@medisin.uio.no.; Barjesteh van Waalwijk van Doorn-Khosrovani S; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands; CZ Health Insurance, Tilburg, The Netherlands. sahar.van.waalwijk@cz.nl.; Steen Carlsson K; Swedish Institute for Health Economics, Lund, Sweden. katarina.steen_carlsson@ihe.se.; Ryll B; Stockholm School of Economics Institute for Research, Stockholm, Sweden. Bettina.Ryll@hhs.se.; Jalkanen K; Clinical Trial Unit, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland. katriina.jalkanen@hus.fi.; Edsjö A; Department of Clinical Genetics, Pathology and Molecular Diagnostics, Region Skåne, Malmö, Sweden. anders.edsjo@skane.se.; Russnes HG; Institute for Cancer Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Pathology, Oslo University Hospital, Oslo, Norway. h.e.g.russnes@medisin.uio.no.; Lassen U; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. ulrik.lassen@regionh.dk.; Hallersjö Hult E; Stockholm School of Economics Institute for Research, Stockholm, Sweden. ebba.hallersjo.hult@hhs.se.; Lugowska I; Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland. Iwona.Lugowska@nio.gov.pl.; Blay JY; Centre Léon Bérard, Lyon, France. jean-yves.blay@lyon.unicancer.fr.; Verlingue L; Centre Léon Bérard, Lyon, France. Loic.VERLINGUE@lyon.unicancer.fr.; Abel E; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden. edvard.abel@vgregion.se.; Lowery MA; Trinity St James Cancer Institute, Trinity College, Dublin, Ireland. MLOWERY@tcd.ie.; Krebs MG; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK. matthew.krebs@nhs.net.; Staal Rohrberg K; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. kristoffer.staal.rohrberg@regionh.dk.; Ojamaa K; Hematology-Oncology Clinic at Tartu University Hospital, Tartu, Estonia. Kristiina.Ojamaa@kliinikum.ee.; Oliveira J; Instituto Português de Oncologia do Porto FG, Porto, Portugal. julio.oliveira@ipoporto.min-saude.pt.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. h.verheul@erasmusmc.nl.; Voest EE; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. e.voest@nki.nl.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands. a.j.gelderblom@lumc.nl.
Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE
Academic Journal
Prenen H; University Hospital Antwerp, Edegem, Belgium.; Deva S; Auckland City Hospital, Auckland, New Zealand.; Keam B; Seoul National University Hospital, Seoul, Korea (South), Republic of.; Lindsay CR; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Lugowska I; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Yang JC; National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan, Taipei, Taiwan.; Longo F; Ramón y Cajal University Hospital, IRYCIS, Universidad Alcala, CIBERONC, Madrid, Madrid, Spain.; de Miguel M; START-CIOCC Early Phase Clinical Trial Unit, HM Sanchinarro Hospital/San Pablo CEU University, Madrid, Spain.; Ponz-Sarvise M; Cancer Center Clinica Universidad de Navarra and solid tumor program, CIMA, Pamplona, Spain.; Ahn MJ; Sungkyunkwan University School of Medicine, Seoul, Korea (South), Republic of.; Gumus M; Istanbul Medeniyet University, School of Medicine, Istanbul, Turkey.; Champiat S; Gustave Roussy, Villejuif, France.; Italiano A; Institut Bergonié, Bordeaux, France.; Salas S; Aix-Marseille University, MARSEILLE, France.; Perets R; Rambam Health Care Campus and Technion--Israel Institute of Technology, Haifa, Israel.; Arslan C; Izmir Economy University Medical Point Medical Hospital, Izmir, Turkey.; Cho BC; Yonsei University College of Medicine, Seoul, Korea (South), Republic of.; Evers S; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Boetsch C; Roche (Switzerland), Basel, Switzerland.; Marbach D; Roche Innovation Center Basel, Basel, Switzerland.; Dejardin D; Roche (Switzerland), Basel, Switzerland.; Sleiman N; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.; Ardeshir C; Roche Products Ltd, United Kingdom.; Richard M; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center, Basel, Switzerland.; Charo J; Roche (Switzerland), Schlieren, Zurich, Switzerland.; Kraxner A; Roche (Switzerland), Basel, Switzerland.; Keshelava N; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland.; Teichgräber V; Roche (Switzerland), Basel, Switzerland.; Moreno V; START-Madrid-FJD, Hospital Fundación Jimenez Diaz, Madrid, Spain.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Lugowska I; Department of Early Phase Clinical Trials, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Becker JC; Department of Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital of Essen, Essen; Department of Translational Skin Cancer Research, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.; Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.; Veness M; Sydney Medical School, The University of Sydney, Sydney; Department of Radiation Oncology, Westmead Hospital, Sydney, Australia.; Blom A; CARADERM Network, Department of General and Oncologic Dermatology, Université Paris-Saclay, UVSQ, EA4340-BECCOH, AP-HP, Ambroise-Paré Hospital, Boulogne-Billancourt.; Lebbe C; Université de Paris Cite, Paris; Dermato-Oncology and CIC Department, AP-HP Hôpital Saint Louis, Paris; INSERM U976, Paris, France.; Migliano E; Department of Plastic and Regenerative Surgery, San Gallicano Dermatological Institute IRCCS, Rome, Italy.; Hamming-Vrieze O; Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Goebeler M; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.; Kneitz H; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.; Nathan P; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.; Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw.; Slowinska M; Department of Dermatology, Military Institute of Medicine-National Research Institute, Warsaw, Poland.; Schadendorf D; Department of Dermatology, Westdeutsches Tumorzentrum (WTZ), University Hospital Essen, Essen; German Cancer Consortium (DKTK), Partner Site Essen & NCT-West Campus Essen & University Alliance Ruhr, Research Center One Health, Essen, Germany.; Piulats JM; Medical Oncology Department, Institut Català d'Oncologia (ICO), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIBEROnc, Universitat de Barcelona, Barcelona, Spain.; Petrelli F; Oncology Unit, Azienda Socio Sanitaria Territoriale (ASST) Bergamo Ovest, Treviglio, Italy.; van Akkooi ACJ; Department of Melanoma and Surgical Oncology, Melanoma Institute Australia, Sydney; Faculty of Medicine and Health, University of Sydney, Sydney; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia.; Berruti A; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology Unit, University of Brescia, ASST Spedali Civili, Brescia, Italy.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Skalicky A; Evidera, Seattle, WA, United States.; Bennett B; Bristol Myers Squibb, Uxbridge, United Kingdom.; Raimbourg J; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, St Herblain, France.; Lonardi S; Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.; Correll J; Evidera, Seattle, WA, United States.; Lugowska I; Maria Sklodowska Curie National Cancer Institute of Oncology, Warsaw, Poland.; Dixon M; Bristol Myers Squibb, Lawrenceville, NJ, United States.; Sargalo N; Evidera, London, United Kingdom.; Martin ML; Evidera, Seattle, WA, United States.
Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Academic Journal
Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Palmerini E; Osteoncologia, Sarcomi dell'osso e dei tessuti molli, e Terapie Innovative, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.; Quagliuolo V; Department of Surgery, IRCCS Humanitas Research Hospital, Rozzano, Italy.; Martin Broto J; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Madrid, Spain.; University Hospital General de Villalba, Madrid, Spain.; Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD, UAM), Madrid, Spain.; Lopez Pousa A; Department of Cancer Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Grignani G; Department of Cancer Medicine, Ospedale Città della Scienza e della Salute, Torino, Italy.; Brunello A; Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto IOV, IRCCS, Padova, Italy.; Blay JY; Department of Cancer Medicine, Centre Léon Bérard Cancer Center, UNICANCER & Université Claude Bernard, Lyon, France.; Tendero O; Department of Surgery, Hospital Universitari Son Espases, Palma de Mallorca, Spain.; Diaz Beveridge R; Department of Cancer Medicine, Hospital Universitari i Politècnic La Fe, Valencia, Spain.; Ferraresi V; Department of Cancer Medicine, Istituto Regina Elena, Rome, Italy.; Lugowska I; Department of Soft Tissue/Bone Sarcoma and Melanoma, Centrum Onkologii, Instytutim, Marii Sklodowskiej-Curie, Warszawa, Poland.; Pizzamiglio S; Unit of Bioinformatics and Biostatistics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Verderio P; Unit of Bioinformatics and Biostatistics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Fontana V; Department of Epidemiology, Clinical Trial Center, IRCCS Ospedale Policlinico San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.; Donati DM; Orthopaedic Oncology Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.; Palassini E; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Sanfilippo R; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Bianchi G; Orthopaedic Oncology Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.; Bertuzzi A; Department of Cancer Medicine, IRCCS Humanitas Research Hospital, Rozzano, Italy.; Morosi C; Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Pasquali S; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Stacchiotti S; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Bagué S; Department of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Coindre JM; Department of Pathology, Institut Bergonié, Bordeaux, France.; Miceli R; Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Dei Tos AP; Department of Pathology, University of Padua, Padova, Italy.; Casali PG; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Meric-Bernstam F; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX.; Makker V; Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY.; Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Oh DY; Seoul National University Hospital; Cancer Research Institute, Seoul National University College of Medicine; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea.; Banerjee S; Gynaecology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom.; González-Martín A; Medical Oncology Department and Programme in Solid Tumours-CIMA, Cancer Center Clínica Universidad de Navarra, Madrid, Spain.; Jung KH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Ługowska I; Early Phase Clinical Trials Unit and Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Manso L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Manzano A; Experimental Therapeutics in Cancer (UTEC), Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain.; Melichar B; Department of Oncology, Palacký University Medical School and University Hospital, Olomouc, Czech Republic.; Siena S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda and the Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Piazza dell'Ospedale Maggiore, Milan, Italy.; Stroyakovskiy D; Healthcare Department, Moscow City Oncology Hospital No. 62, Moscow, Russia.; Fielding A; Oncology R&D, AstraZeneca, Gaithersburg, MD.; Ma Y; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Puvvada S; Oncology R&D, AstraZeneca, Gaithersburg, MD.; Shire N; Oncology R&D, AstraZeneca, Gaithersburg, MD.; Lee JY; Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, South Korea.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Clingan P; Southern Medical Day Care Centre, Wollongong, New South Wales, Australia.; Ladwa R; Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia.; Brungs D; Southern Medical Day Care Centre, Wollongong, New South Wales, Australia.; Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.; Harris DL; Christchurch Hospital, Christchurch, New Zealand.; McGrath M; Medical Oncology, Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, Queensland, Australia.; Arnold S; Exellentis Clinical Trial Consultants, George, South Africa.; Coward J; ICON Cancer Centre, South Brisbane, Queensland, Australia.; Fourie S; Wilgers Oncology Centre, Pretoria, South Africa.; Kurochkin A; Municipal Nonprofit Enterprise of Sumy Regional Council Sumy Regional Clinical Oncology Dispensary, Sumy, Ukraine.; Malan DR; Phoenix Pharma, Port Elizabeth, South Africa.; Mant A; Medical Oncology Unit, Eastern Health, Melbourne, Victoria, Australia.; Sharma V; Wits Clinical Research Chris Hani Baragwanath Clinical Trial Site, Johannesburg, South Africa.; Shue H; Sunshine Coast Haematology and Oncology Clinic, Buderim, Queensland, Australia.; Tazbirkova A; Medical Oncology, Pindara Private Hospital, Gold Coast, Queensland, Australia.; Berciano-Guerrero MA; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain.; Charoentum C; Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand.; Dalle S; Hospices Civils de Lyon - Hopital Lyon Sud, Pierre-Bénite, France.; Dechaphunkul A; Songklanagarind Hospital, Prince of Songkla University, Songkhla, Thailand.; Dudnichenko O; Kharkiv Medical Academy of Postgraduate Education, Chair of Oncology and Children's Oncology, Clinical base State institution 'VT Zaycev Institute of General and Urgent Surgery of National Academy Medical Sciences of Ukraine', Kharkiv, Ukraine.; Koralewski P; Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie Sp. z o.o., Oddział Onkologii Klinicznej z Pododdziałem Dziennym, Kraków, Poland.; Lugowska I; Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Oddział Badań Wczesnych Faz, Warsaw, Poland.; Montaudié H; Centre Hospitalier Universitaire de Nice - Hôpital l'Archet, Nice, France.; Muñoz-Couselo E; Hospital Universitario Vall d'Hebron, Passeig de la Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Sriuranpong V; King Chulalongkorn Memorial Hospital, Bangkok, Thailand.; Oliviero J; Checkpoint Therapeutics Inc, Waltham, Massachusetts, USA jfo@checkpointtx.com.; Desai J; Department of Medical Oncology, Peter MacCallum Cancer Centre; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Pant S; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: spant@mdanderson.org.; Schuler M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.; Iyer G; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.; Witt O; Hopp Children's Cancer Center (KiTZ), Heidelberg University Hospital, German Cancer Research Center and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Doi T; National Cancer Center Hospital East, Kashiwa, Japan.; Qin S; Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing, China.; Tabernero J; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), IOB-Quiron, Barcelona, Spain.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Massard C; Le Kremlin Bicêtre-France INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Université Paris-Saclay, Paris, France.; Minchom A; The Royal Marsden NHS Foundation Trust, Sutton, UK.; Lugowska I; Department of Soft Tissue/Bone Sarcoma and Melanoma, Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie-Panstwowy Instytut Badawczy, Warsaw, Poland.; Carranza O; Hospital Privado de Comunidad de Mar del Plata, Mar del Plata, Argentina.; Arnold D; Department of Oncology, AK Altona, Asklepios Tumourzentrum Hamburg, Hamburg, Germany.; Gutierrez M; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.; Winter H; Bristol Haematology and Oncology Centre, Bristol, UK.; Stuyckens K; Janssen Research & Development, Beerse, Belgium.; Crow L; Janssen Research & Development, Spring House, PA, USA.; Najmi S; Janssen Research & Development, Spring House, PA, USA.; Hammond C; Janssen Research & Development, Spring House, PA, USA.; Thomas S; Janssen Research & Development, Spring House, PA, USA.; Santiago-Walker A; Janssen Research & Development, Spring House, PA, USA.; Triantos S; Janssen Research & Development, Spring House, PA, USA.; Sweiti H; Janssen Research & Development, Spring House, PA, USA.; Loriot Y; Department of Cancer Medicine, INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: Yohann.LORIOT@gustaveroussy.fr.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Lugowska I
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어